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Abstract
The mitochondrial genome encodes just a small number of subunits of the respiratory chain. All the other mitochondrial
proteins are encoded in the nucleus and produced in the cytosol. Various enzymes participate in the activation and intrami-
tochondrial transport of imported proteins. To ®nally take their place in the various mitochondrial compartments, the targeting
signals of imported proteins have to be cleaved by mitochondrial processing peptidases. Mitochondria must also be able to
eliminate peptides that are internally synthesized in excess, as well as those that are improperly assembled, and those with
abnormal conformation caused by mutation or oxidative damage. Damaged mitochondrial proteins can be removed in two
ways: either through lysosomal autophagy, that can account for at most 25±30% of the biochemically estimated rates of average
mitochondrial catabolism; or through an intramitochondrial proteinolytic pathway. Mitochondrial proteases have been exten-
sively studied in yeast, but evidence in recent years has demonstrated the existence of similar systems in mammalian cells, and
has pointed to the possible importance of mitochondrial proteolytic enzymes in human diseases and ageing. A number of
mitochondrial diseases have been identi®ed whose mechanisms involve proteolytic dysfunction. Similar mechanisms probably
play a role in diminished resistance to oxidative stress, and in the aging process. In this paper we review current knowledge of
mammalian mitochondrial proteolysis, under normal conditions and in several disease states, and we propose an etiological
classi®cation of human diseases characterized by a decline or loss of function of mitochondrial proteolytic enzymes. q 2001
Elsevier Science B.V. and Mitochondria Research Society. All rights reserved.
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1. Introduction
Mitochondria are essential for respiration and
oxidative energy production in aerobic cells, where
they are also required for multiple biosynthetic reac-
tions pathways. Mitochondrial homeostasis is very
important for cell survival, and a disequilibrium in
the production or degradation of various mitochon-
drial components can lead to accumulation of non-
assembled subunits, mitochondrial dysfunction, and
even cell death.
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The turnover of mitochondrial proteins was once
believed to be conducted by lysosomes through autop-
hagy of the whole organelle. This non-selective
removal of mitochondrial proteins was shown to
take place in yeast, under the in¯uence of starvation
conditions (Takeshige et al., 1992). Lysosomal autop-
hagy, however, cannot explain differences in the turn-
over rates of various mitochondrial proteins (Walker
et al., 1978; Lipsky and Pedersen, 1981): while most
mitochondrial proteins are stable for 3.5±5 days in
mammalian cells, g-aminolevinulate synthase for
example has a half-life of only 20±80 min (Russel et
al., 1980, 1982; Dice and Goldberg, 1975). A morpho-
metric electron microscopy study has shown that lyso-
somal autophagy can account for at most 20±25% of
biochemically estimated rates of mitochondrial
protein catabolism in hepatocytes (Pfeifer, 1987).
Also, when hepatocytes are treated with a¯atoxin
B1, general cellular proteolysis is signi®cantly inhib-
ited, yet the degradation of mitochondrial proteins is
unaffected (Brookes et al., 1984).
These ®ndings suggests that mitochondria posses a
well-developed proteolytic pathway which mediates
the selective degradation of mitochondrial proteins.
At least ®ve different proteases or proteinases, and at
least three processing peptidases have been described
in eukaryotic mitochondria. Two of the proteases, the
Lon protease and the Clp protease are homologues of
the bacterial La and Ti proteases. A third group is
represented by the AAA metalloprotease family, i-
AAA and m-AAA, which are mitochondrial homolo-
gues of bacterial FtsH. Recently, a new ATP-stimu-
lated protease was described and partially puri®ed
from the rat liver mitochondrial intermembrane
space; the MISP1, or mitochondrial intermembrane
space protease (Sitte et al., 1995). Another two new
serine proteases with thrombin-like activity were
isolated from the membrane fraction of the rat submax-
illary gland (Bharadwaj et al., 1994, 1996). The exact
functions of these proteases and their physiological
substrates are only partially understood.
Another proteolytic system in mitochondria is
involved in the processing of nuclear encoded mito-
chondrial components. Most mitochondrial proteins
are encoded by nuclear genes, synthesized in the cyto-
plasm, and then translocated into mitochondria. These
cytoplasmically produced pre-proteins posses a mito-
chondrial-targeting sequence (MTS) attached at the
amino-terminal portion of the pre-sequence. Once
translocated into the matrix, the pre-proteins are
processed ®rst by the mitochondrial matrix processing
peptidase (with the a-MPP and b-MPP subunits) then
by the mitochondrial intermediate peptidase (MIP),
the inner membrane protease I, and probably by
other as yet uncharacterized peptidases, before being
folded by a complex chaperone system.
In this present paper we review the structure and
function of both the degradative ATP-stimulated
proteases (Lon, Clp, AAA) and the ATP-independent
processing peptidases (MPP, MIP, inner membrane
protease I) and discuss current knowledge of the
pathologies related to dysfunction of these proteolytic
systems.
2. ATP-stimulated proteases in mitochondria
2.1. The Lon protease
An ATP-stimulated proteolytic activity has been
described in the matrix of mitochondria from a variety
of eukaryotic cells, including the rat liver (Desautels
and Goldberg, 1982a,b; Rapport et al., 1982); bovine
adrenal cortex (Watabe and Kimura, 1985a,b); human
heart, brain, and liver (Wang et al., 1993); human
placenta (Ishii et al., 1992); and human germ cells
during spermiogenesis (Meinhardt et al., 1999).
Extracts prepared from the mitochondrial matrix are
able to degrade labeled proteins such as casein, and
can also selectively degrade oxidized protein
substrates (Marcillat et al., 1988).
The mitochondrial matrix protease responsible for
this activity was puri®ed by two different groups from
rat liver mitochondria as a 600 kDa hexameric homo-
protein complex (subunit mass 106 kDa) (Desautels
and Goldberg, 1982b) and from bovine adrenal cortex
as a 650 kDa protein (subunit size on SDS gel is 106
kDa) (Watabe and Kimura, 1985a,b). The human
enzyme, later obtained by in vitro transcription and
translation, had an apparent molecular weight of 107
kDa, and, upon incubation with mitochondrial extract,
was converted to an 100 kDa mature form (Wang et
al., 1994). The Lon protease seems to be expressed in
all human tissues, but the mRNA and protein levels
are highest in heart, brain, liver and skeletal muscle
(Wang et al., 1993).
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The optimum pH for Lon protease activity is 7.8, and
the enzyme displays all the classical characteristics of a
serine protease (inhibited by PMSF) with a cysteine
residue close to the catalytic site (inhibition by
NEM). The enzyme does not actually require ATP
for the degradation of either proteins or ¯uorescent
polypeptides substrates, but protein degradation is
stimulated to up to nine-fold by ATP (Watabe and
Kimura, 1985b). All these features match the well-
known activity of protease La (product of the Lon
gene) from Escherichia coli (E. coli). When the protein
sequence was solved for humans (Wang et al., 1993)
and yeast (van Dyck et al., 1994; Suzuki et al., 1994), it
displayed signi®cant homology with the known E. coli
La sequence; 38% identity between bacterial La and
human Lon proteases, and 33% identity between
bacterial La and yeast PIM 1 (Amerik et al., 1994;
Wang et al., 1993; Suzuki et al., 1994). When
expressed in E. coli, the cloned human sequence is
fully functional and can degrade casein in an ATP-
stimulated manner (Wang et al., 1993). The yeast
Dpim1 mutant has a respiratory de®ciency and is
unable to maintain functional mitochondrial DNA
(van Dyck et al., 1998a; van Dyck and Langer,
1999). This strain lacks a functional Lon gene and
also has impaired ability to degrade mitochondrial
matrix proteins, which tend to accumulate as elec-
tron-dense inclusions (Suzuki et al., 1994). The strain
can be rescued by expressing bacterial protease La
(Teichmann et al., 1996).
The function of the Lon protease in mammalian
mitochondria is not yet fully understood. It has been
proposed that the adrenal gland bovine protease Lon
might participate in the degradation of adrenodoxin
reductase and cytochrome P-450 (Watabe et al.,
1993). Another proposed protein substrate is the SP-
22 mitochondrial protein (Watabe et al., 1994). This
novel protein has analogies with the thiol-speci®c
antioxidant gene (TSA) product from S. cerevisiae
and has the ability to scavenge reactive oxygen
species (Watabe et al., 1995). Mitochondria are the
major site of intracellular free radical production
(Davies et al., 1982; Davies and Hochstein, 1982;
Davies and Doroshow, 1986; Doroshow and Davies,
1986; Cadenas and Davies, 2000) and mitochondrial
proteins are subject to high rates of oxidative modi®-
cation and inactivation, both as a result of normal
aerobic metabolism (Davies, 1986a; Zhang et al.,
1990) and in response to various drugs and environ-
mental toxins (Marcillat et al., 1989).
That mitochondria contain a proteolytic system
which can recognize and selectively degrade oxida-
tively modi®ed internal proteins has been known for
over 15 years (Davies, 1986a,b, 1988; Dean and
Pollak, 1985; Marcillat et al., 1988) and has been
proposed as an important protective mechanism
(Cadenas and Davies, 2000; Davies, 1986a, 1995,
2001). New data from our laboratory (Bota and
Davies, 2000) indicate that the Lon protease may
play a key role in this important process. We ®nd
that the Lon protease can selectively degrade oxida-
tively modi®ed aconitase, and may thus play an
important role in defending against the accumulation
of oxidized proteins in mitochondria. The hypothesis
that the Lon protease might protect against mitochon-
drial protein damage from free radicals during oxida-
tive stress and aging is interesting in light of
experimental evidence that expression of the Lon
protease declines about four-fold in ageing murine
skeletal muscles, and that this phenomenon can be
prevented by caloric restriction (Lee et al., 1999).
Furthermore, it was realized quite early that there
were several striking similarities between the degra-
dation of oxidized proteins in mitochondria and the
degradation of oxidized proteins in bacteria (Davies
and Lin, 1988a,b).
Similar to its bacterial counterpart, the human Lon
protease is able to bind to mitochondrial promoters,
and may control mitochondrial DNA replication and
gene expression by degrading regulatory proteins
involved in replication (Fu and Markovitz, 1998).
Finally, Lon might have a role in mitochondrial
biogenesis. In cells with an increased mitochondrial
biogenesis, such as Zajdela hepatoma tumor or hepa-
tocytes from thyroid hormone-treated rats, an
enhanced level of Lon expression and protease activ-
ity has been reported (Luciakova et al., 1999).
2.2. AAA proteases
Studies of the stability of mitochondrial translation
products in yeast have revealed the presence of an
ATP-dependent proteolytic activity in the inner mito-
chondrial membrane (Kalnov et al., 1979a,b; Yasu-
hara et al., 1994). Most components of the
respiratory chain embedded in the inner mitochondrial
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membrane are encoded by the nuclear genome, but a
few are encoded by the mitochondrial genome. Poly-
peptide subunits encoded by both genomes are
required for the assembly of complete mitochondrial
electron transport chain complexes. In the absence of
the cytoplasmically synthesized polypeptides, non-
assembled subunits of mitochondrial provenance are
subject to rapid proteolysis in the inner membrane
(Nakai et al., 1994). Two different members of the
AAA family (ATPase Associated with a variety of
cellular Activities), m-AAA and i-AAA metallopro-
tease have been identi®ed as being responsible for
this activity. AAA proteases constitute a large and
highly conserved family of enzymes, with members
universally present in eukaryotic as well as bacterial
cells (Langer, 2000). The best studied bacterial
member is the E. coli FtsH metalloprotease
(Tomoyasu et al., 1993). In yeast mitochondria, muta-
tions at the m-AAA or i-AAA proteolytic sites impair
the degradation of non-assembled inner membrane
proteins and the assembly of respiratory chain
complexes (Pajic et al., 1994; Leonhard et al., 1996;
Arlt et al., 1998). The catalytic sites of these two AAA
proteases are exposed to opposite membrane surfaces.
This membrane arrangement was hypothesized to
assure the recognition and degradation of non-
assembled or misfolded polypeptides on either face
of the mitochondrial inner membrane surface, as
well as integral membrane proteins which expose
just a few amino acids to the outside face of the
inner membrane (Leonhard et al., 2000).
The m-AAA protease is an 850 kDa membrane-
embedded complex, consisting of multiple copies of
the ATP-dependent metallopeptidases Yta10p
(Afg3p) and Yta12p (Rca1p), that acts on the matrix
side of the mitochondrial inner membrane (Arlt et al.,
1996). This complex is involved in the degradation of
cytochrome c oxidase and ATP-synthase subunits
(Guelin et al., 1996). The m-AAA protease displays
overlapping substrate speci®city with the PIM1
protease (the yeast homologue of the Lon protease),
both of them being able to degrade the same model
protein (bovine apocytochrome P450scc) in vivo, and
to collaborate with the mtHsp70 system (Savel'ev et
al., 1998). The proteolytic activity of the m-AAA
complex is inhibited by prohibitins (Steglich et al.,
1999), a family of proteins implicated in the regula-
tion of cellular replicative lifespan (Coates et al.,
1997) and mitochondrial morphology (Berger and
Yaffe, 1998). In higher eukaryotes, the prohibitins
have suggested functions in senescence (Dell'Orco
et al., 1996) and tumor suppression (Nuell et al.,
1991). Another function of the Yta10-12p complex
is a chaperone-like activity, required for assembly of
the membrane associated ATP synthase (Arlt et al.,
1996).
The i-AAA protease, is also approximately an 850
kDa multimeric protein, composed of Yta11p
(Yme1p) subunits, but it is active in the intermem-
brane space. The i-AAA protease is also involved in
the degradation of cytochrome c oxidase, speci®cally
degrading the mitochondrially encoded subunit 2p
(Nakai et al., 1995), in collaboration with m-AAA
protease (Leonhard et al., 1996). The AAA domain
of the Yme1p protein also has chaperone-like activity,
being able to bind unfolded peptides and to promote
their refolding and/or to speci®cally degrade unfolded
membrane proteins (Leonhard et al., 1999). Loss of
the chaperone function of both AFG3 and YME1 is
lethal for yeast cells (Lemaire et al., 2000).
Paraplegin, the product of the SPG7 gene, is a
human homologue of the yeast Yta proteins, showing
55, 52 and 55% identity, respectively with Yta10p,
Yta11p and Yta12p (Pearce, 1999). The SPG7 gene
is located on chromosome 16q24.3 (De Michele et al.,
1998), a region where several genes involved in
human pathology have been mapped. These include
the gene responsible for Fanconi's anemia (Fanconi
Anaemia/Breast Cancer Consortium, 1996), the cell
matrix adhesion regulator gene, CMAR (Durbin et al.,
1997) which seems to be able to suppress tumor inva-
sion in lymphoblastic cell lines, and the melanocyte-
stimulating hormone receptor (Mountjoy et al., 1992)
The same chromosome region has been described as
showing frequent loss of heterozygosity (LOH), a
situation commonly seen in sporadic breast cancer
(Clenton-Jansen et al., 1994; Tsuda et al., 1994) and
prostate cancer (Suzuki et al., 1996). Mutations in the
SPG7 gene were shown to cause the autosomal reces-
sive form of hereditary spastic paraplegia (Casari et
al., 1998), a neurodegenerative disorder characterized
by progressive degeneration of the cortico-spinal
axons, with early onset paraparesis, ataxia and retini-
tis. The complete sequence of the gene has been
described (Settasatian et al., 1999), and it is interest-
ing to note that the CMAR cDNA sequence actually
D.A. Bota, K.J.A. Davies / Mitochondrion 1 (2001) 33±4936
represents an aberrant splicing form of SPG7, which
suggest the possibility that this gene is also involved
in the control of cellular proliferation.
Immuno¯uorescence analysis and import experi-
ments have shown that Paraplegin localizes to mito-
chondria (Casari et al., 1998). The predicted size of
the mature protein is 81 kDa. Although SPG7 mRNA
expression is ubiquitous in human tissues, it does
exhibit both developmental and tissue variation in
steady-state concentration. The levels in the adult
brain, heart, muscle and thymus are higher than in
the corresponding fetal tissues. A high level of expres-
sion was also discovered in the adrenal and salivary
glands (Settasatian et al., 1999; Casari et al., 1998).
Mitochondrial analysis of muscle biopsy samples
from patients carrying various mutations (deletions,
frame shift mutations) in the SPG7 gene have revealed
signs of both impaired oxidative phosphorylation
(OXPHOS), and excessive proliferation of subsarco-
lemmal and intermyo®brillar mitochondria with
bizarre morphology (ragged-red ®bers), as an ineffec-
tive compensatory mechanism for the OXPHOS
defect (Casari et al., 1998).
Another three members of the AAA-family of
proteases/chaperones were identi®ed by blasting the
known sequences of the yeast AAA- metalloproteases
and the ®rst described human homologue, paraplegin,
against the human genome. AFG3L1 is a homologue
of Afg3p (Yta10p) and Rca1p (Yta12p) and is located
on the telomeric region of the chromosome 16q24.
The sequence of this protein suggested a mitochon-
drial localization (Shah et al., 1998).
The second Afg3p human homologue is AFG3L2, a
gene mapped to chromosome 18p11 (Ban® et al.,
1999). AFG3L2 exhibits higher homology (69% simi-
larity and 59% identity) to Afg3p (Yta10p) and Rca1p
(Yta12p) than to paraplegin (58.3% similarity and
49% identity). Immuno¯uorescence analysis revealed
that AFG3L2 co-localizes to mitochondria. Northern
analysis of human adult and fetal tissues have uncov-
ered a ubiquitous pattern of expression, with highest
levels in human heart and skeletal muscles. The chro-
mosome region 18p11 was not found to be involved in
any of the forms of hereditary spastic paraplegia, but
is associated with one of the loci for a another group
of movement disorders; idiopathic torsion dystonia
(Leube et al., 1996), for which this gene may well
be a candidate. Two another genes causing torsion
dystonia, the TOR1 A and TOR1B were also identi-
®ed in family studies and cloned (Ozelius et al., 1989,
1999). These highly homologous genes are localized
on human chromosome 9q34, and have also been
characterized, based on their sequences, as members
of the AAA-family of proteases/chaperones (Ozelius
et al., 1999). The exact functions and cell localization
of those genes, as well as the mechanism(s) of their
involvement in pathology are not yet clear.
The YME1L1 gene was identi®ed as a human
homologue of the yeast Yme1p gene (50% identity),
and mapped to chromosome 10p14 (Coppola et al.,
2000). Two gene transcripts were identi®ed, which are
most abundant in human adult heart, skeletal muscles
and pancreas. In the mouse embryo the gene was
expressed in all tissues analyzed. Based on the
predicted protein structure and the results of
epitope-tagged protein experiments, this homologue
is also thought to localize to mitochondria. The func-
tion of this protein is highly conserved from yeast to
humans, and YME1L1 expression can rescue a yeast
Yme1 disrupted strain (Shah et al., 2000). Similar to
the other newly described human AAA-mitochondrial
proteases, no speci®c function or mechanism in
human pathology has yet been described.
A recent advance in our understanding of the mito-
chondrial AAA metalloprotease family came with
analysis of the two metazoan completed genomes,
those of Caenorhabditis elegans and Drosophila
melanogaster, and the construction of the phyloge-
netic tree including the already known members
from humans and yeast (Juhola et al., 2000). Three
computer-predicted genes were later identi®ed in the
Drosophila genome: CG6512 (homologue of human
AFG3L2 and yeast Afg3p and Rca1p), CG3499 (with
human YME1L and yeast Yme1p) and CG2658 (with
human paraplegin). In C. elegans, two predicted genes
were found: Y47G6A.10 and M03C11.5, and a puta-
tive third member was also proposed in an un®nished
region of chromosome 4. Mutants of signi®cant inter-
est have not yet been described for any of the
metazoan homologues (Juhola et al., 2000). The
proposed phylogenetic tree establishes three main
branches, represented by the yeast YME1, human
paraplegin, and yeast AFG3 and RCA1 together, as
duplications of the same original gene. The fact that
a member of the paraplegin subfamily is not present in
yeast may imply that this enzyme could be involved in
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processing of mitochondrial proteins that are only
present in the animal kingdom.
2.3. ClpP-ClpA/X complex
The Clp protease complex (also named protease Ti)
was identi®ed and ®rst puri®ed in E. coli (Katayama et
al., 1987, 1988; Hwang et al., 1987; Hwang et al.,
1988). This ATP-dependent protease is formed by
two different subunits: a proteolytic component,
ClpP and an ATP-hydrolyzing chaperone component,
ClpA (Gottesman et al., 1990a) or ClpX (Gottesman
et al., 1993).
Clp P, the proteolytic component is a homotetrade-
cameric serine protease (Maurizi et al., 1990a,b;
Kessel et al., 1995; Weissman et al., 1995; Wang et
al., 1997, 1998). The active protease is a cylinder
composed of 14 identical subunits organized in two,
seven-fold symmetrical rings. The structure of the
entrance/exit pores and the proteolytic chamber in
ClpP is very similar to the b proteolytic rings of the
proteasome complex from yeast and Thermoplasma
acidophilum proteasome, eukaryotic 20S proteasome,
and the E. coli HsIV (Wang et al., 1998). A probable
evolutionary relationship between ClpP and the
proteasome can be argued based on their common
mechanisms of substrate recognition and transloca-
tion (Gottesman et al., 1997a), similar kinetics of
their chymotrypsin-like activity and the cross-reaction
of the af®nity-puri®ed anti-ClpP antibodies with two
polypeptide components of the proteasome (Arribas
and Castano, 1993). In E. coli, ClpP alone displays
intrinsic peptidase activity against some short
peptides (Katayama-Fujimura et al., 1988; Arribas
and Castano, 1993; Thompson and Maurizi, 1994;
Thompson et al., 1994), but the presence of the regu-
latory component ClpA/X is needed for ATP-stimu-
lated protein degradation, and is also responsible for
substrate selection (Wickner et al., 1994; Gottesman
et al., 1997a). Speci®c targets of ClpXP include the
lO factor (Gottesman et al., 1993; Wojtkowiak et al.,
1993), starvation sigma (sS) factor (Schweder et al.,
1996), SsrA-tagged proteins generated from defective
mRNA (Gottesman et al., 1998), and MuA transpo-
sase (Levchenko et al., 1997). The best described
target of ClpAP is the RecA protein (Pak et al., 1999).
ClpP is very well conserved across the evolutionary
ladder, with homologues of the bacterial enzyme iden-
ti®ed by cDNA analysis of the chloroplast genome
from rice, tobacco, liverwort (Maurizi, 1990b), and
Arabidopsis (Nakabayashi et al., 1999), as well as in
the fully sequenced C. elegans genome (de Sagarra et
al., 1999). A genomic search did not reveal any ClpP
yeast homologue in the fully sequenced yeast genome
(Van Dyck et al., 1998b). A human member of this
family (HClpP) has been cloned (Bross et al., 1995).
HClpP is 53% identical with the E. coli protease and it
contains an N-terminal extension including a matrix
targeting signal (Bross et al., 1995), characteristic of
proteins encoded in the nucleus and transported into
mitochondria. The mitochondrial localization of
HClpP has been con®rmed by immuno¯uorescence
and electron microscopic studies (Corydon et al.,
1998; de Sagarra et al., 1999). Antibodies against
HClpP preferentially bind a 26 kDa mature protein
in the mitochondrial fractions from human and rat
liver, similar in size to the translation protein obtained
from an N-truncated (without the targeting sequence)
version of HClpP cDNA (de Sagarra et al., 1999).
When puri®ed, the N-truncated recombinant protein
has a native molecular weight of 340 kDa, the equiva-
lent of an homotetradecameric enzyme. Electron
microscopic studies have con®rmed that the structure
of the human protein is composed of two rings, each
of them made from seven identical subunits (de
Sagarra et al., 1999), the same as the crystal confor-
mation of E. coli ClpP (Wang et al., 1997).
ClpA and ClpX are members of a large family of
Clp-like energy-dependent chaperones, the Hsp100/
Clp chaperon family (Schirmer et al., 1996), which
are widely conserved in both prokaryotic and eukaryo-
tic cells (Gottesman et al., 1990b, 1997b). ClpA-like
proteins were identi®ed based either on their cDNA
sequences or by cross-hybridization with a bacterial
protein probe, in the chloroplasts of Arabidopsis
(Nakashima et al., 1997; Nakabayashi et al., 1999),
in the eukaryotic parasite T. brucei, in C. elegans,
and in Drosophila melanogaster (Gottesman et al.,
1990b). Expression of Erd1, the ClpA-like gene from
Arabidopsis, is up-regulated by senescence (natural
and dark-induced) as well as by water stress such as
dehydration or high-salinity (Nakashima et al., 1997;
Nakabayashi et al., 1999). A mammalian member of
the ClpA family has not yet been described.
A number of eukaryotic ClpX homologues have
been described. These include the genes Mcx1p (Mito-
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chondrial ClpX) of Saccharomyces cerevisiae (van
Dyck et al., 1998a,b) and murine ClpX (Santagata et
al., 1999), and two predicted protein products of the
C. elegans and Arabidopsis genomes (van Dyck et al.,
1998a,b). Both the yeast and the mouse ClpX genes
have mitochondrial-targeting sequences and their
proteins both co-localize in GFP-tagged form to the
mitochondrial matrix, probably associating with the
inner membrane. Using the mouse ClpX, a chromo-
somal location for the human gene was mapped to
chromosome 15q22.2-22.3 (Santagata et al., 1999).
2.4. Mitochondrial intermembrane space protease
(MISP I)
Another ATP-stimulated proteolytic activity
distinct from the i-AAA protease has been described
in the intermembrane space of rat liver mitochondria
(Sitte et al., 1995). MISP I has a molecular mass of
200 kDa (according to its sedimentation rate) and
appears to be an oligomeric enzyme complex,
containing at least one 60 kDa subunit with ATP-
binding properties. In the presence of ATP, the degra-
dation of a ¯uorescent polypeptide by MISP I is
increased up to three-fold. Based on its inhibition
pro®le, this novel protease was characterized as a
cysteine protease sensitive to hemin. Interesting
MISP I displays multiple catalytic activities, such as
chymotrypsin-like, peptidyl-glutamyl-hydrolyzing
and trypsin-like activities; classic activities of the
20S proteasome. It is also very interesting that
MISS I (the ATP-binding subunit of MISP I), also
cross-reacts with an antibody raised against the
ATP-binding subunit S4 of the 26S proteosome
(Sitte et al., 1998), possibly evidence of a common
ancestry. Preliminary peptide sequence analysis
revealed 80% identity with a plant AAA-ATPase
(Sitte et al., 1998), consistent with identi®cation of
the S4 protein as a member of the same family. This
strong identity raises the question of whether this
protease might be similar to one of the human
AAA-proteases discovered by the genetic analysis of
the human genome, which we reviewed in the
previous section of this paper.
2.5. Mitochondrial proteases with thrombin-like
activity
Recently, two new mitochondrial membrane
proteases have been extracted and puri®ed to homo-
geneity from rat submaxillary mitochondrial
membranes (Bharadwaj et al., 1994, 1996). The mole-
cular weight of one enzyme was 22 kDa when deter-
mined by its SDS-gel electrophoretic mobility, and 24
kDa when determined from the elution point on a
Sephadex G-100 column (Bharadwaj et al., 1994).
The second protease had a molecular weight of 45
kDa (Bharadwaj et al., 1996). The two enzymes
have similar properties, for example both are active
between pH 7.0 and 9.5, with maximum activity at pH
8.5. Both proteolytic activities are inhibited by diiso-
propyl ¯uorophosphate, benzamide and antipappain,
suggesting that they are serine proteases. The puri®ed
enzymes are able to coagulate rabbit plasma by a
mechanism involving the formation of ®brin clots
from puri®ed ®brinogen. The physiological role of
these proteins in intramitochondrial processing is
presently unknown, and we have no idea if they are
actually involved in blood coagulation
2.6. Summary of ATP-stimulated proteases in
mitochondria
The spectrum of ATP-stimulated intramitochon-
drial proteinases or proteases discussed above, is
reviewed in Table 1.
3. ATP-independent processing peptidases in
mitochondria
3.1. Mitochondrial processing peptidase
The majority of nuclear-encoded mitochondrial
proteins are synthesized as precursors containing a
leader peptide, or pre-sequence, that targets the pre-
protein to the mitochondria (Rosenberg et al., 1986;
Pfanner and Neupert, 1990; Glick and Schatz, 1991;
Omura 1998). Once transported inside the mitochon-
drial matrix, the precursor's matrix targeting signal
(or `MTS') is recognized and cleaved in one step by
the mitochondrial processing peptidase (MPP). In
order to be recognized, a MTS should be at least 40
amino acids long, and should contain basic amino
acids upstream of the cleavage site (Ou et al., 1994).
Mutation on the N-terminal targeting signal (espe-
cially at the basic amino acid residues) can greatly
reduce the processing ef®cacity of MPP (Song et al.,
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1996; Ito, 1999). For most proteins cleavage of the
MTS by MPP is enough for full activation, for a speci-
®c subgroup the consecutive action of another pepti-
dase is required (Hendrick et al., 1989; Isaya et al.,
1991).
The mitochondrial processing peptidase is a hetero-
dimer composed of two subunits: a larger `a-MPP'
subunit which is responsible for the binding of the
mitochondrial presequences, and a smaller `b-MPP'
catalytic active subunit (Luciano et al., 1997; Saave-
dra-Alanis et al., 1994). Both a-MPP and b-MPP
subunits have been puri®ed and described from
various organisms and have been given a confusing
series of different names such as PEP (processing
enhanced protein) and MPP in the fungus Neurospora
crassa (Hawlitschek et al., 1988; Schneider et al.,
1990; Brunner and Neupert, 1995), Mas 1 and Mas
2 in yeast (Yang et al., 1988, 1991; Geli et al., 1990),
and P-52 and P-55 in rat (Ou et al., 1989). Some MPP
subunits from different species are able to comple-
ment one another (Adamec et al., 1999). The current
accepted nomenclature for the subunits is a-MPP and
b-MPP (Kalousek et al., 1993).
Puri®ed rat liver MPP subunits exhibit molecular
weights of 55 kDa for a-MPP and 50 kDa for b-MPP
(Kalousek et al., 1988; Ou et al., 1989). Both the
subunits have been cloned and sequenced (Kleiber
et al., 1990; Paces et al., 1993). The enzyme behaves
like a Zn-metallopeptidase, in that it requires Zn 21 or
other divalent cations for its activation and it is inhib-
ited by metal chelators (Luciano et al., 1998).
The gene responsible for Friedreich ataxia (FRDA),
an autosomal recessive neurodegenerative disease
(Harding, 1981), encodes a protein called frataxin
(Campuzano et al, 1996, 1997) that is localized in
mitochondrial membranes (Priller et al., 1997). In
yeast, de®ciencies of the frataxin homologue results
in iron overload, increased production of free radicals,
and marked decreases in mitochondrial function
(Babcock et al., 1997). Frataxin is produced as a larger
precursor, which is activated either by MPP cleavage
alone (Branda et al., 1999), or by MPP cleavage in
collaboration with another peptidase (Koutnikova et
al., 1998). The mutant protein causing Freidreich
ataxia is cleaved by MPP at a much slower rate than
is the wild-type frataxin, and this delay in maturation
also contributes to a decline in the frataxin function
(Koutnikova et al., 1998).
3.2. Mitochondrial intermediate peptidase
In order to be fully activated, a number of nuclear-
encoded mitochondrial proteins targeted to the mito-
chondrial matrix also require selective cleavage of
their amino-terminus, which still remains after proteo-
lytic removal of the leader peptide by the mitochon-
drial intermediate peptidase or `MIP' (Brunner and
Neupert, 1995; Isaya et al., 1991). The N-terminal frag-
ment cleaved is an octapeptide motif (F, I or L)-X-X-
(S,T or G)-X-X-X-X (Hendrick et al., 1989, Gavel and
von Heijne, 1990) which directs recognition of the
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Table 1
Mammalian mitochondrial homologues of bacterial and yeast proteases
E. coli protease Yeast protease Mammalian protease Location
La Pim1p Lon Matrix
FtsH metalloprotease Afg3p/Yta10p AFG3L1 Inner membrane, facing matrix (yeast)
AFG3L2
Rca1p/Yta12p Paraplegin Inner membrane, facing matrix (yeast)
Yme1p/Yta11p YME1L1 Inner membrane
ClpPA/X(Ti protease) no ClpP HclpP Matrix
No ClpA ClpA not tested
Mcx1p (yeast ClpX) ClpX Matrix
MISP I Intermembrane space
MPTA Membrane fraction
intermediate protein precursor by MIP and its proces-
sing to the mature protein (Isaya et al., 1992a).
The MIP was puri®ed from the rat liver mitochon-
drial matrix (Kalousek et al., 1992) as a 75 kDa mono-
mer. The enzyme is active between pH 6.6 and 8.9 and
is inhibited by thiol-blocking reagents such as N-
ethylmaleimide. The enzyme is a metalloprotease,
requiring divalent cations (such as Mn21, Mg21 and
Ca21) and is inhibited by EDTA. The rat cDNA of
MIP has been cloned (Isaya et al., 1992b) and the
sequence encodes a 710 amino acid protein, including
an N-terminal leader peptide of 33 amino acids. In
vitro, the precursor of MIP is processed to its mature
form by MPP. The predicted protein sequence does
not contain an octapeptide motif and MIP is not
involved in its own proteolytic activation (Isaya and
Kalousek, 1995). Analysis of the deduced MIP
sequence has revealed homologies to a yeast protein
with no proven function, and to a subfamily of zinc
metallopeptidases (Isaya and Kalousek, 1995).
3.3. Inner membrane protease I
In yeast, several mitochondrially targeted pre-
proteins, such cytochrome b2, are produced from
nuclear transcripts in the cytoplasm, then cleaved
upon entry into the mitochondrial matrix by the MPP
peptidase which removes the N-terminal matrix-
targeting signal. The complete activation, and release
of the mature forms of such proteins in the aqueous
intermembrane space, also requires the activity of
another peptidase (Daum et al. 1982; Gasser et al.,
1982). This activity has been attributed to the Inner
Membrane Protease I, which is also the peptidase
involved in the activation of at least one mitochond-
rially synthesized polypeptide, cytochrome oxidase
subunit II (Sevarino and Poyton, 1980; Pratje et al.,
1983). The inner membrane protease I proteolytic
activity was localized, by mitochondrial fractionation,
to the inner membrane (Schneider et al., 1991). In the
absence of this activity, e.g. in yeast mutants such as
the pet ts2858 strain, the precursors of both cytochrome
b2 and cytochrome oxidase subunit II accumulate.
When the pet2858 gene was cloned, it was shown
that it encodes a protein with a predicted size of 21.4
kDa. Since over-expression of this gene does not lead
to an increase in the peptidase activity however, it
seems likely that PET2858 is just one of the subunits
of a hetero-oligomeric peptidase complex.
3.4. Mitochondrial diseases of proteolysis with
unknown mechanism-Batten disease
Batten disease or neuronal ceroid lipofuscinosis is a
heterogenous group of neurodegenerative lysosomal
diseases, with the late infantile, juvenile and adult
forms characterized by accumulation of mitochon-
drial F1F0-ATP synthase subunit 9 (Kominami et al.,
1992; Palmer et al., 1992) in lysosomal storage bodies
in many tissues. Patients develop brain and retinal
atrophy, blindness, seizures, paralysis and death
(Gobel, 1992; Rider et al., 1992). The hydrophobic
modi®cation of the F1F0-ATP synthase subunit 9,
which seems to play a role in the disease process,
involves an unusual lysine methylation in the stored
protein (Katz et al., 1995). The proteolytic defect in
the degradation of the F1F0-ATP synthase subunit 9 is
proposed to be mitochondrial in origin, because lyso-
somal macroautophagy is normal in ®broblasts
derived from affected individuals (Tanner and Dice,
1996; Tanner et al., 1997).
3.5. Summary of ATP-independent processing
peptidases in mitochondria
The spectrum of ATP-independent mammalian
mitochondrial processing peptidases discussed
above, is reviewed in Table 2.
4. Summary and proposed etiological classi®cation
of mitochondrial proteolytic diseases
4.1. Summary
Mitochondrial proteolytic mechanisms in mammals
are very complex, a feature required to maintain the
fragile equilibrium between components encoded by
the mitochondrial genome and produced in the mito-
chondrial matrix, and components encoded by the
nuclear genome and translocated from the cell cyto-
plasm. Once fully activated, both categories of mito-
chondrial proteins are subjected to intense oxidative
stress, which may explain the relatively short half-life
of most mitochondrial component. When the stochio-
metry of the respiratory chain subunits is out of equi-
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librium the unassembled subunits need to be promptly
degraded. Both the activation of pre-proteins, and the
recognition and degradation of damaged proteins are
catalyzed by a series of mitochondrial proteolytic
enzymes with speci®c localizations in different mito-
chondrial compartments. Diminished function or
dysfunction of any of these enzymes can have grave
consequences for mitochondrial activity and for survi-
val of the whole cell or organism. An overview of the
locations of the mitochondrial proteases and proces-
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Table 2
Mammalian mitochondrial homologues of the yeast processing peptidases
Yeast peptidase Mammalian peptidase Location Function
Mas 1 a-MPP Matrix Recognition and cleavage of the mitochondrial targeting sequence
Mas 2 b±MPP
MIP MIP Matrix Cleavage of an octapeptide motif in selected targets (already processed by MPP)
IMP I None yet Inner membrane Maturation of a number of polypeptides (already processed by MPP) localized in
the intermembrane space
Fig. 1. Schematic representation of the mammalian mitochondrial proteases. Some intramitochondrial locations of mammalian homologues
were interfered from the location of corresponding subunits in yeast). The round shapes symbolize ATP-stimulated proteases and their
regulatory subunits, the square shapes are the processing peptidases. (With the additional symbols representing * enzymes described only in
yeast thus far and 1 enzymes described only in Arabidopsis so far). MISP I, mitochondrial intermembrane space protease; MPTA, mitochondrial
proteases with thrombin-like activity; MPP, mitochondrial processing peptidase; MIP, mitochondrial intermediate peptidase; IMP I, inner
membrane protease I.
sing peptidases is presented in Fig. 1. It should be
recognized that Fig. 1 contains both well documented
mammalian enzymes, as well as a few enzymes whose
existence or location in mammalian mitochondria is
only proposed or inferred from yeast studies.
In this paper we have reviewed existing knowledge
of both the normal functions and the associated pathol-
ogies of mitochondrial proteolytic systems in
mammals, and in lower organisms. We would also
like to propose a novel etiological classi®cation of
mitochondrial pathology caused by development
(ageing) regulation and by the misfunction of proteo-
lytic enzymes.
4.2. Proposed etiological classi®cation of
mitochondrial proteolytic diseases
1. Age-related changes in protease expression:
± Lon protease: expression of the Lon protease
declines during ageing. The Lon protease is
responsible for degrading modi®ed/oxidized
protein (Bota and Davies, 2000). A decrease in
its activity might explain the accumulation of
oxidative adducts in mitochondria puri®ed
from old human tissues, and contribute to the
mitochondrial fragility associated with normal
ageing which is exacerbated in pathological
conditions such as sarcopenia in elderly
patients.
± ClpA protease: expression of the ClpA protease
is up-regulated during senescence in Arapidop-
sis. A mammalian counterpart has not yet been
described, but this protein is highly conserved
between lower species, which makes its
presence probable also in higher eukaryotes.
The up-regulation of ClpA expression could be
either a compensatory mechanism for the down-
regulation of Lon protease, or a cause for
exacerbated degradation of matrix metabolic
enzymes and essential regulatory proteins (see
the substrates of the ClpPA/X described in E.
coli).
2. Decrease or loss of function caused by mutations or
deletions in the encoding genes: human AAA
proteases:
± Paraplegin (SPG7 gene product): mutations in
the SPG7 gene are the cause of the autosomal
recessive form of hereditary spastic paraplegia.
This gene is widely expressed in human tissues
and this can explain the differences in the
phenotypes of different patients, as well as
why the SPG7 gene could be also involved in
leukemia/lymphoma, sporadic breast and
prostatic cancer (loss of proliferation control)
and Fanconi anemia.
± AFG3L2, TOR1A and TOR1B: mutations in the
coding regions of these three genes were shown
to be associated with different forms of another
movement disorder, idiopathic torsion dystonia.
3. Decrease or loss of proteolytic activity caused by
modi®cation of a speci®c substrate:
± Mitochondrial processing peptidase and
frataxin: mutations in the coding region of
frataxin, the protein responsible for Friedreich
ataxia, lead to the production of a modi®ed
protein, with decreased function, which is not
properly recognized and activated by MPP clea-
vage. Delayed maturation of frataxin further
diminishes the availability of the active protein
in the mitochondrial matrix.
± Mitochondrial protease (not yet identi®ed) and
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Table 3
Mitochondrial proteolytic defects associated with human disorders
Protease Defect Disorder Reference
Lon Down-regulation Ageing Lee et al., 1999
Paraplegin Mutation Hereditary spastic paraplegia Casari et al., 1999
AFG3L2 Mutation Idiopathic torsion dystonia(?) Ban® et al., 1999
TOR1A/B Mutation Idiopathic torsion dystonia Ozelius et al., 1999
MPP Slower recognition of a modi®ed substrate Friedreich ataxia Branda et al., 1999; Koutnikova et al., 1998
Unknown Inability to process a modi®ed substrate Batten disease (neuronal
ceroid lipofuscinosis)
Katz et al., 1995; Tanner and Dice, 1996
F0F1-ATP synthase subunit 9: lysosomal accu-
mulation of mitochondrial F0F1-ATP synthase
subunit 9, the cause of neuronal ceroid lipofus-
cinosis (Batten disease), is hypothesized to be
caused by an inef®cient degradation of the
hydrophobically modi®ed polypeptide, by an
as yet unidenti®ed mitochondrial proteolytic
system.
5. Conclusions
A number of mitochondrial diseases have been
identi®ed whose mechanisms involve proteolytic
dysfunction. These diseases and a proposed etiologi-
cal classi®cation are summarized in Table 3. Similar
mechanisms probably play a role in the aging process
and diminished resistance to oxidative stress. Exten-
sive further study of human mitochondrial proteolytic
systems, including mechanistic studies of enzymatic
function and elucidation of substrate recognition, is
required in light of the number of severe mitochon-
drial conditions of unknown etiology.
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